Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
Open Access
- 31 May 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 6, 73
Abstract
Transcatheter aortic valve replacement (TAVR) has recently emerged as an effective alternative to medical treatment or surgical aortic valve replacement in all symptomatic patients with severe aortic stenosis and high or prohibitive risk and in intermediate risk when transfemoral access is feasible. Patients undergoing TAVR are often at high risk for either bleeding or cerebrovascular complications, or both, so adjuvant antithrombotic therapies are commonly used before, during and after the procedure. Today, there is no clear evidence on the best antithrombotic regimen in this context. In this review, we will try to go through the mechanisms involved in bleeding and embolic complications and we will discuss the current points of antithrombotic treatment in patients during and after TAVR, with or without oral anticoagulation (OAC) indication.Keywords
This publication has 44 references indexed in Scilit:
- Comparison of Two Antiplatelet Therapy Strategies in Patients Undergoing Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2014
- Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve ReplacementCirculation, 2013
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)European Journal of Cardio-Thoracic Surgery, 2012
- 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: Executive summaryThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position StatementCanadian Journal of Cardiology, 2012
- Clinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium DefinitionsJACC, 2012
- Percutaneous closure of left atrial appendage after transcatheter aortic valve implantation - an interventional approach to avoid anticoagulation therapy in elderly patients: TAVI and closure of LAA to avoid warfarin therapyEuroIntervention, 2012
- Dual Antiplatelet Therapy Versus Aspirin Alone in Patients Undergoing Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2011
- Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelinesEuroIntervention, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010